Jailendra Singh
Stock Analyst at Truist Securities
(0.92)
# 3,999
Out of 5,138 analysts
184
Total ratings
28.43%
Success rate
-23.45%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Buy | $52 | $44.15 | +17.78% | 1 | Jan 12, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $265 → $290 | $233.69 | +24.10% | 18 | Jan 8, 2026 | |
| ICLR ICON Public Limited Company | Downgrades: Hold | $231 → $222 | $176.57 | +25.73% | 11 | Jan 8, 2026 | |
| FTRE Fortrea Holdings | Upgrades: Buy | $12 → $22 | $15.82 | +39.06% | 1 | Jan 8, 2026 | |
| PRVA Privia Health Group | Reiterates: Buy | $30 → $31 | $23.21 | +33.56% | 8 | Nov 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $16 → $10 | $3.94 | +153.81% | 8 | Nov 10, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $436 → $555 | $602.40 | -7.87% | 6 | Oct 27, 2025 | |
| PHR Phreesia | Maintains: Buy | $35 → $36 | $15.73 | +128.86% | 7 | Sep 8, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $48 → $37 | $30.47 | +21.43% | 11 | Aug 18, 2025 | |
| WAY Waystar Holding | Maintains: Buy | $50 → $51 | $29.74 | +71.49% | 3 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $24 → $27 | $25.38 | +6.38% | 10 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $61 | $41.10 | +48.42% | 9 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $41.62 | +15.33% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $6.07 | +48.27% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.60 | +111.54% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $4.60 | +63.04% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $26.21 | +75.51% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $216.26 | -2.89% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.63 | +31.70% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $0.98 | +565.51% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $3.58 | +263.13% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $2.27 | +957.27% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.55 | +158.06% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $210.37 | -72.43% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $2.28 | +1,873.68% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $821.84 | -59.48% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $2.59 | +247.49% | 2 | May 19, 2021 |
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $52
Current: $44.15
Upside: +17.78%
IQVIA Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $265 → $290
Current: $233.69
Upside: +24.10%
ICON Public Limited Company
Jan 8, 2026
Downgrades: Hold
Price Target: $231 → $222
Current: $176.57
Upside: +25.73%
Fortrea Holdings
Jan 8, 2026
Upgrades: Buy
Price Target: $12 → $22
Current: $15.82
Upside: +39.06%
Privia Health Group
Nov 10, 2025
Reiterates: Buy
Price Target: $30 → $31
Current: $23.21
Upside: +33.56%
Evolent Health
Nov 10, 2025
Maintains: Buy
Price Target: $16 → $10
Current: $3.94
Upside: +153.81%
Medpace Holdings
Oct 27, 2025
Maintains: Hold
Price Target: $436 → $555
Current: $602.40
Upside: -7.87%
Phreesia
Sep 8, 2025
Maintains: Buy
Price Target: $35 → $36
Current: $15.73
Upside: +128.86%
Hims & Hers Health
Aug 18, 2025
Maintains: Hold
Price Target: $48 → $37
Current: $30.47
Upside: +21.43%
Waystar Holding
Jul 17, 2025
Maintains: Buy
Price Target: $50 → $51
Current: $29.74
Upside: +71.49%
Jul 17, 2025
Maintains: Hold
Price Target: $24 → $27
Current: $25.38
Upside: +6.38%
Jul 17, 2025
Maintains: Hold
Price Target: $52 → $61
Current: $41.10
Upside: +48.42%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $41.62
Upside: +15.33%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $6.07
Upside: +48.27%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.60
Upside: +111.54%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $4.60
Upside: +63.04%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $26.21
Upside: +75.51%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $216.26
Upside: -2.89%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.63
Upside: +31.70%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $0.98
Upside: +565.51%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $3.58
Upside: +263.13%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $2.27
Upside: +957.27%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.55
Upside: +158.06%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $210.37
Upside: -72.43%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $2.28
Upside: +1,873.68%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $821.84
Upside: -59.48%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $2.59
Upside: +247.49%